Dynamic Technology Lab Private LTD Ultragenyx Pharmaceutical Inc. Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$43.02 - $53.69 $675,930 - $843,577	15,712 New	15,712 $734,000
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $255,100 - $356,184	-6,830 Reduced 49.17%	7,060 $326,000
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $513,791 - $676,581	13,890 New	13,890 $557,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $837,162 - $1.39 Million	20,950 New	20,950 $868,000
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $796,342 - $1.05 Million	-10,220 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$92.19 - $115.71 $942,181 - $1.18 Million	10,220 New	10,220 $974,000
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $194,237 - $304,765	-1,817 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$84.4 - $177.39 $153,354 - $322,317	1,817 New	1,817 $252,000
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $488,877 - $661,804	-8,900 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$39.87 - $69.36 $354,843 - $617,304	8,900 New	8,900 $617,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.